A possible role for implantable naltrexone in the management of the high-risk pregnant heroin user.
Hulse
G K
GK
King Edward Memorial Hospital, and the Australian Medical Procedures Research Foundation, University Department of Psychiatry and Behavioural Science, University of Western Australia, Nedlands, Australia.
O'Neill
G
G
D000328:Adult; D004305:Dose-Response Relationship, Drug; D004343:Drug Implants; D005260:Female; D005500:Follow-Up Studies; D005865:Gestational Age; D006556:Heroin Dependence / Q000517:prevention & control* / Q000534:rehabilitation*; D006801:Humans; D008431:Maternal-Fetal Exchange; D009271:Naltrexone / Q000008:administration & dosage*; D009292:Narcotic Antagonists / Q000008:administration & dosage*; D010349:Patient Compliance; D011247:Pregnancy; D011256:Pregnancy Outcome; D018566:Pregnancy, High-Risk; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*; D016896:Treatment Outcome
D004343:Drug Implants; D009292:Narcotic Antagonists; D009271:Naltrexone